NANOG and breast cancer: In conclusion, in three independent autochthonous mouse models of melanoma and breast cancer we could find no evidence to support the notion that Oct4 and Nanog are expressed in the tumors, excluding the possibility that these transcriptional regulators determine the stemness properties of CSCs in these models.